Pheochromocytoma MRI

	Pheochromocytoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Pheochromocytoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pheochromocytoma MRI On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pheochromocytoma MRI All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pheochromocytoma MRI
CDC on Pheochromocytoma MRI
Pheochromocytoma MRI in the news
Blogs on Pheochromocytoma MRI
Directions to Hospitals Treating Pheochromocytoma
Risk calculators and risk factors for Pheochromocytoma MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]

Overview

Head, neck, chest, and abdominal MRI may be helpful in the diagnosis of pheochromocytoma.

T1 slightly hypointense to the remainder of the adrenal gland, if there is a necrosis and/or haemorrhage then the signal will be more heterogeneous
T2 markedly hyperintense (lightbulb sign, helpful in the diagnosis), areas of necrosis/haemorrhage/calcification will alter signal
T1 C+ (Gd) heterogenous enhancement is prolonged, persisting for as long as 50 minutes 4